Danaher Corporation

Stock Chart, Company Information, and Scan Results

$190.47(as of Sep 16, 4:00 PM EST)

Stock Market Guides is not a financial advisor. Our content is strictly educational and should not be considered financial advice.

Danaher Corporation Company Information, Fundamentals, and Technical Indicators

Stock Price$190.47
Ticker SymbolDHR
ExchangeNyse
SectorHealthcare
IndustryDiagnostics & Research
Employees61,000
CountyUSA
Market Cap$136,085.5M
EBIDTA7,521.0M
10-Day Moving Average194.85
P/E Ratio40.13
20-Day Moving Average201.08
Forward P/E Ratio22.17
50-Day Moving Average200.60
Earnings per Share4.68
200-Day Moving Average207.38
Profit Margin9.35%
RSI37.12
Shares Outstanding716.1M
ATR4.92
52-Week High278.43
Volume2,862,844
52-Week Low170.73
Most Recent Support Level187.04
Book Value52,342.0M
Most Recent Resistance Level199.15
P/B Ratio2.62
Upper Keltner212.15
P/S Ratio5.70
Lower Keltner190.02
Debt-to-Equity Ratio212.15
Next Earnings Date10/21/2025
Cash Surplus-3,835.0M
Next Ex-Dividend Date09/26/2025

Danaher Corporation designs, manufactures, and markets professional, medical, research, and industrial products and services in the United States, China, and internationally. It operates through Biotechnology, Life Sciences, and Diagnostics segments. The Biotechnology segment provides bioprocessing technologies, consumables, services, and solutions that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, and aseptic fill finish; single-use hardware, consumables, and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services for diagnostic and assay development; and healthcare filtration solutions. The Life Sciences segment provides mass spectrometers; bioanalytical measurement systems; flow cytometry, genomics, lab automation, centrifugation, liquid handling automation instruments, antibodies, and particle counting and characterization; genome sample preparation; microscopes; protein consumables; filtration products; and genomic medicines, such as custom nucleic acid products, and plasmid DNA, RNA, and proteins under the ABCAM, ALDEVRON, BECKMAN COULTER, GENEDATA, IDT, LEICA MICROSYSTEMS, MOLECULAR DEVICES, PALL, PHENOMENEX, and SCIEX brands. The Diagnostics segment offers clinical instruments, consumables, software, and services in the areas of clinical chemistry, immunoassay, hematology, and microbiology for hospitals, physicians' offices, reference laboratories, and other critical care settings. The company was formerly known as Diversified Mortgage Investors, Inc. and changed its name to Danaher Corporation in 1984. Danaher Corporation was founded in 1969 and is headquartered in Washington, the District Of Columbia.

Danaher Corporation In Our Stock Scanner

As of Sep 17, 2025
As of ---
As of ---

Join Our Free Email List

Get emails from us about ways to potentially make money in the stock market.